Our findings were in agreement with other previous reports showing a higher NM23-H1 expression in tumor had a favorable response to radiotherapy in laryngeal and nasopharyngeal cancers (21, 22). The gene discussed is NME1; the disease is nasopharyngeal carcinoma.